The concentration of maternal sacubitril/valsartan transferred into human milk is negligible

• Prif Awduron: Sirin Falconi (Awdur), Abiodun Okimi (Awdur), Shaun Wesley (Awdur), Pooja Sethi (Awdur), Palika Datta (Awdur), Kaytlin Krutsch (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2024-05-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

BackgroundPeripartum cardiomyopathy (PPCM) is a common cause of heart failure (HF) in the peripartum. Some medications are considered safe while breastfeeding. However, sacubitril/valsartan (Entresto), while efficacious, is not recommended in breastfeeding women due to concerns about adverse infant...